Home › Funds › Eukles Asset Management › RMD
Eukles Asset Management position in RMD
RESMED INC · Health Care
Eukles Asset Management reported holding 18,669 shares of RMD (RESMED INC) in its Q3 2026 13F filing — a position valued at US$4.1M, representing 1.65% of its reported portfolio and ranking #19 among its reported holdings. Eukles Asset Management has disclosed RMD holdings in 13 of the last 13 reported quarters, going back to Q3 2023.
Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR
How Eukles Asset Management's RMD position evolved
Eukles Asset Management first disclosed a stake in RMD in Q3 2023 at 22,363 shares (US$3.3M). The position peaked in Q3 2025 at 22,865 shares, worth US$6.3M. Across 13 filings, Eukles Asset Management increased the stake 2 time(s), trimmed it 4 time(s) and left it unchanged 6 time(s). The most recent filing (Q3 2026) shows 18,669 shares valued at US$4.1M.
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2023 | 22.36K | $3.31M | New |
| Q4 2023 | 22.37K | $3.85M | Hold |
| Q1 2024 | 23.27K | $4.61M | Add |
| Q2 2024 | 23.36K | $4.47M | Hold |
| Q3 2024 | 23.27K | $5.68M | Hold |
| Q4 2024 | 22.33K | $5.11M | Reduce |
| Q1 2025 | 22.89K | $5.13M | Add |
| Q2 2025 | 22.94K | $5.92M | Hold |
| Q3 2025 | 22.86K | $6.26M | Hold |
| Q4 2025 | 22.74K | $5.48M | Reduce |
| Q1 2026 | 19.41K | $4.36M | Reduce |
| Q2 2026 | 18.76K | $3.66M | Reduce |
| Q3 2026 | 18.67K | $4.13M | Hold |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About RMD and 13F data
RMD (RESMED INC) is a Health Care company. 31 other funds we track also report a position in RMD — the largest reported positions include Ilex Capital Partners (UK) LLP (US$163.1M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding RMD
- Ilex Capital Partners (UK) LLP 737.47K sh · $163.06M · Q3 2026
More on Eukles Asset Management
FAQ
How long has Eukles Asset Management held RMD?
Eukles Asset Management has disclosed RMD holdings in 13 of the last 13 reported quarters, going back to Q3 2023.
What is Eukles Asset Management's current position in RMD?
As of Q3 2026, Eukles Asset Management holds 18.67K shares of RMD (RESMED INC), valued at $4.13M, representing 1.65% of its reported portfolio and ranking #19.
Has Eukles Asset Management been buying or selling RMD?
In the latest 13F filing (Q3 2026), Eukles Asset Management held unchanged its position in RMD. The position peaked in Q3 2025 at 22.86K shares.
Which other funds hold RMD?
Other major institutional holders of RMD include Ilex Capital Partners (UK) LLP, among 31 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.